World of DTC Marketing
NOVEMBER 16, 2021
SUMMARY: Omnichannel marketing employs the simultaneous implementation of channels across personal, non-personal, and media and addresses the integrated needs of multiple stakeholders – consumers/patients, healthcare professionals, and payers. Sounds good but is that the answer? There is no doubt that healthcare is the middle of an evolution not seen in over 30 years.
New to Medical Device Sales
NOVEMBER 15, 2021
You can listen here: [link] You can watch here: [link] What’s the difference between a full line sales rep (TM ) and an associate sales rep (ASR)? Associate Sales Rep (ASR) The job of an associate rep is to make the full line reps life easier. They will be doing all the things the TM doesn’t want/have time to do. Majority of the times the ASR will be spending their time: Covering cases Running trays/equipment Helping with territory daily task There will be other duties for the ASR, but from my e
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Clarivate
NOVEMBER 16, 2021
Today we unveil our annual list of Highly Cited Researchers. We congratulate some 6,600 scientists and social scientists for demonstrating significant influence among their peers in their chosen field (or fields) through the publication of multiple highly cited papers during the last decade. These highly cited papers rank in the top 1% by citations for field and year from 2010 – 2020.
Medical Device Success
NOVEMBER 14, 2021
Reading time: 2 – 3 minutes. Today’s guest is Patricia Zilliox, CEO of Eyevensys, a clinical stage biotechnology company based in Paris, France and Dallas, Texas. Patricia is running a very exciting startup that combines a medical device and gene-therapy that is targeting some of the biggest causes of blindness. The idea behind this biotechnology is the brainchild of Founder Francine Behar-Cohen, MD, PhD.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
World of DTC Marketing
NOVEMBER 15, 2021
SUMMARY: Physicians are tired and overwhelmed with medical information on new drugs. They don’t have the time to sit in the office and search for more information, and they feel that pharma is giving them “too much” information. An exciting development presented itself. A client launched an Oncology drug based on extensive research with physicians, but the results were not that good during a post-launch evaluation.
Fierce Pharma
NOVEMBER 15, 2021
A new way to access scientific papers? admin. Mon, 11/15/2021 - 12:01.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Prognos Health
NOVEMBER 19, 2021
Understanding the longitudinal patient journey — from symptoms to testing, to diagnosis and treatment — is a standard and essential part of any life science company’s business practice.
World of DTC Marketing
NOVEMBER 18, 2021
SUMMARY: AbbVie continues to profit from Americans by repeatedly raising U.S. prices on its widely-used Humira rheumatoid arthritis drug while cutting the price abroad. AbbVie exploits the U.S. patent system to fend off competitors and increased the price of Humira to $77,000 for a year’s supply, while the price of its cancer drug Imbruvica was raised to $181,529 per year.
Axxelus
NOVEMBER 19, 2021
Mistakes happen in every profession. The medical sales industry is no exception. However, some errors can be costlier than others when it comes to medical sales mistakes. In today’s post, we’ll examine some common sales mistakes, why mistakes happen, and some strategies for reducing your risks.
Clarivate
NOVEMBER 17, 2021
Women leaders at Clarivate like Ann Graul play a key role in accelerating innovation in the quest for answers to COVID-19 issues. Watch their story. The global COVID-19 pandemic that began in early 2020 turned the world as we knew it upside down, bringing unimagined challenges and exacerbating existing struggles. It impacted how people work and the progress and speed of broader problem-solving.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharmatutor
NOVEMBER 19, 2021
WHY PM MODI ADDRESSED, INDIA AS THE PHARMACY OF THE WORLD. Recently, during inauguration of Global Innovation Summit of the pharmaceuticals sector Indian Prime Minister Shri Narendra Modi addressed, India as the Pharmacy of the world. He said that our definition of wellness is not limited by physical boundaries. We have exported life-saving medicines and medical equipment to over 150 countries during the initial phase of the pandemic.
Prognos Health
NOVEMBER 18, 2021
Datavant , the leader in helping healthcare organizations securely connect their data and a Prognos Health partner, recently held its Future of Health Data Summit in Washington DC. This in-person event brought healthcare leaders together to discuss emerging opportunities and challenges around the use of health data to improve patient outcomes.
ALULA
NOVEMBER 18, 2021
“ Leaders don’t force people to follow, they invite them on a journey ” – Charles S. Lauer. This article is co-authored by Dee Conway and Bridget Russell, Ed.D. There’s been a great deal of dialogue on the return to office (or RTO). From business need, to timing, to individual impacts, the discussion has been… robust, to put it lightly. But what if you as a leader are considering whether it’s time for your team to return.
Clarivate
NOVEMBER 17, 2021
In this episode of Conversations in Healthcare , Carolyn Hynes from AstraZeneca discusses the importance of regulatory intelligence. In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership, Life Science & Healthcare at Clarivate, speaks with Carolyn Hynes, Director of Regulatory Intelligence at AstraZeneca and Celine Rodier, Senior Health Policy Manager at Clarivate about the importance of regulatory intelligence and its potential return investment for co
Advertiser: ZoomInfo
Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr
LEVO Health
NOVEMBER 16, 2021
In the medical marketing world, it can sometimes be challenging to produce entertaining content that your patients will want to read and engage with. However, there are plenty of tips and tricks you can incorporate into your content to keep patients engaged and coming back for more. Tips for Creating Content Your Patients Want to Read. Do you want the content your practice creates to be read, shared, or commented on?
Prognos Health
NOVEMBER 18, 2021
Datavant , the leader in helping healthcare organizations securely connect their data and a Prognos Health partner, recently held its Future of Health Data Summit in Washington DC. This in-person event brought healthcare leaders together to discuss emerging opportunities and challenges around the use of health data to improve patient outcomes. Prognos CEO Sundeep Bhan was a featured panelist in a session titled The Data Ecosystem in 2025 , which also included leaders from CVS Health, Komodo Heal
Revosuite
NOVEMBER 16, 2021
For pharma companies, medical reps turnover is very costly, from recruitment to training, the process of replacement and handover costs the company money, time, and most importantly momentum. But unfortunately, that's not all! When a medical rep leaves a company, not only does he/she takes institutional knowledge with him/her, but also a range of retinotopic intelligence, customer relationships, and sales.
Infuse Medical
NOVEMBER 16, 2021
Once a buzzing exhibition event that drew companies from near and far, trade shows have since pivoted to virtual booths in response to the COVID-19 global pandemic. Despite this pivot, the objective remains the same – provide companies and exhibitors space and opportunity to engage with attendees, inform them about their brand and products, and generate leads.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Tribeca Knowledge
NOVEMBER 16, 2021
I n another year of considerable turbulence for pharmaceuticals, with COVID-19 continuing to disrupt business strategies and patient access to medicines, regulators and companies alike are finding ways to keep the approval flow coming. The trend for 2021 new drug approvals in both the US and the European Union, the two most important launching pads for innovative medicines worldwide, has more than kept pace with 2020.
Nixon Gwilt Law
NOVEMBER 16, 2021
If you are in the digital health industry, particularly the remote patient monitoring (“RPM”) space, you have likely heard of the remote therapeutic monitoring (“RTM”) codes finalized in the 2022 Medicare Physician Fee Schedule Final Rule (the “Final Rule”). With these new codes set to go into effect January 1, 2022, RPM vendors already in the remote monitoring arena should start preparing now for how they can take advantage of this new reimbursement opportunity.
Curzon Consulting
NOVEMBER 15, 2021
15th November 2021 1 Minutes. If hip and knee implant manufacturers want to stay relevant, and “move the needle” on value creation, they need to play big or go home! An aging (ageing) population is driving absolute sales, but over the past few years, primary hip and knee procedures have become commoditised, which has resulted in margins being squeezed for both hospital providers and implant manufacturers.
Pharmatutor
NOVEMBER 15, 2021
ISO 9000 series requirements in Quality Management Systems : A REVIEW. About Author. Vikas Kumar Prajapati. Organization - Bansal College of Pharmacy, Bhopal(M.P.). Email: vikasprajapati8417@gmail.com. admin. Mon, 11/15/2021 - 16:10. Tags. Articles. Review Articles.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
World of DTC Marketing
NOVEMBER 19, 2021
SUMMARY: The U.S. government has provided Moderna with nearly $10 billion in taxpayer money for research and development and the purchase of 500 million doses of this mRNA COVID-19 vaccine. This includes almost the entire cost of clinical development. Additionally, Moderna used patents and non-exclusive rights that the U.S. government made available to them to make this COVID-19 vaccine.
Nixon Gwilt Law
NOVEMBER 15, 2021
“.almost every month last year more than 1 million people were affected by data breaches at health-care organizations.” — US Dept of Health and Human Services. Over the past year, the healthcare industry has widely embraced the use of telemedicine and digital health platforms largely as a response to the COVID-19 Public Health Emergency. Not surprisingly, the industry also saw a significant rise in the number of cyberattacks.
Toolyt
NOVEMBER 13, 2021
“If everything seems under control, you're not going fast enough,” says Mario Andretti, one of the successful car racing drivers. In the fast-changing world, it is the pace that matters. Everything should happen swiftly but accurately especially in the Business and Sales World. We all would have seen the track relay race right from the school days.
Prognos Health
NOVEMBER 19, 2021
Understanding the longitudinal patient journey — from symptoms to testing, to diagnosis and treatment — is a standard and essential part of any life science company’s business practice. To optimally position your therapy in the market, you need insight into the following questions: How does the disease progress that our therapy is designed to treat?
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Clarify Health
NOVEMBER 15, 2021
Medicare Advantage is expected to reach 40% penetration by 2025. By 2023, available annual profit pools will range from $11 billion to $13 billion, making Medicare Advantage the single biggest driver of profit growth for health care insurance providers ¹. For health plans looking to grow their share of this market, they need to ensure that they’re as competitive as possible.
Cadensee
NOVEMBER 15, 2021
Daniella Gilboa. CEO, AIVF. CEO of AIVF, a company that is out to transform the fertility and IVF treatment journey. Daniella was an embryologist for more than 15 years before establishing AIVF. . Show Notes. 01:15 What are the most memorable milestones that brought you to where you are today? 02:58 What is the driving force behind your passion for Health Technology?
Toolyt
NOVEMBER 13, 2021
“If everything seems under control, you're not going fast enough,” says Mario Andretti, one of the successful car racing drivers. In the fast-changing world, it is the pace that matters. Everything should happen swiftly but accurately especially in the Business and Sales World. We all would have seen the track relay race right from the school days.
Clarify Health
NOVEMBER 15, 2021
Medicare Advantage is expected to reach 40% penetration by 2025. By 2023, available annual profit pools will range from $11 billion to $13 billion, making Medicare Advantage the single biggest driver of profit growth for health care insurance providers¹. For health plans looking to grow their share of this market, they need to ensure that [.].
Advertiser: ZoomInfo
In times of economic uncertainty, account-based strategies are essential. According to several business analysts and practitioners, ABM is a necessity for creating more predictable revenue. Research shows that nearly three-quarters of marketers (74%) already have the resources needed to build successful ABM programs.
Expert insights. Personalized for you.
253 
Let's personalize your content